Organ-sparing radiation therapy for head and neck cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature Reviews Clinical Oncology

• Publication date

  2011-11-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1038/nrclinonc.2011.106PMID 21788974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delineating neck targets for intensity-modulated radiation therapy of head and neck cancer.

  2011cited by this paper
• Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.

  2011cited by this paper
• Radiation-induced cranial nerve palsy: a cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy.

  2011cited by this paper
• Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

  2011cited by this paper
• Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.

  2011cited by this paper
• How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

  2011cited by this paper
• Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.

  2010cited by this paper
• Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.

  2010cited by this paper
• Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

  2010cited by this paper
• Use of normal tissue complication probability models in the clinic.

  2010cited by this paper
• Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.

  2010cited by this paper
• Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases

  2010cited by this paper
• Brachial plexus contouring with CT and MR imaging in radiation therapy planning for head and neck cancer.

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Brachial Plexopathy after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

  2010cited by this paper
• Evidence-based organ-sparing radiotherapy in head and neck cancer.

  2010cited by this paper
• Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

  2010cited by this paper
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

  2010cited by this paper
• Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.

  2009cited by this paper
• Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.

  2009cited by this paper
• Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

  2009cited by this paper
• Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.

  2009cited by this paper
• Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.

  2009cited by this paper
• Radiation dose-volume effects of optic nerves and chiasm.

  2009cited by this paper
• Dysphagia in head and neck cancer.

  2009cited by this paper
• Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy

  2009cited by this paper
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

  2009cited by this paper
• Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update.

  2009cited by this paper
• Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).

  2008cited by this paper
• Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer.

  2008cited by this paper
• Head and neck cancer

  2008cited by this paper
• Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy.

  2008cited by this paper
• Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.

  2008cited by this paper
• Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.

  2008cited by this paper
• Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx.

  2008cited by this paper
• Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy.

  2008cited by this paper
• Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.

  2008cited by this paper
• Postoperative intensity‐modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity

  2008cited by this paper
• Beware the swing and a miss: baseball precautions for conformal radiotherapy.

  2008cited by this paper
• Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.

  2007cited by this paper
• Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions.

  2007cited by this paper
• Radiation-induced brachial plexus neuropathy - aetiopathogenesis, risk factors, differential diagnostics, symptoms and treatment.

  2007cited by this paper
• Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

  2007cited by this paper
• Dosimetric Evaluation of the Brachial Plexus in the Treatment of Head and Neck Cancer

  2007cited by this paper
• Correlation Between Saliva Production and Quality of Life Measurements in Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy

  2007cited by this paper
• The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.

  2007cited by this paper
• Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

  2007cited by this paper
• Delineating neck targets for intensity- modulated radiation therapy of head and neck cancer. What we learned from marginal recurrences?

  2007cited by this paper
• Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma

  2007cited by this paper
• Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters.

  2007cited by this paper
• Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

  2007cited by this paper
• Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.

  2006cited by this paper
• Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.

  2006cited by this paper
• Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

  2006cited by this paper
• Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

  2006cited by this paper
• A prospective study on radiation-induced changes in hearing function.

  2006cited by this paper
• Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy.

  2006cited by this paper
• Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.

  2006cited by this paper
• Radiation‐induced xerostomia in patients with head and neck cancer

  2006cited by this paper
• Osteoradionecrosis of the Mandible

  2006cited by this paper
• Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck.

  2006cited by this paper
• Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer: A local center’s experience

  2006cited by this paper
• Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.

  2006cited by this paper
• Oral complications of radiotherapy.

  2006cited by this paper
• Radiation-related damage to dentition.

  2006cited by this paper
• Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.

  2006cited by this paper
• Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.

  2005cited by this paper
• Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.

  2005cited by this paper
• Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.

  2005cited by this paper
• Intensity-modulated radiotherapy: Is xerostomia still prevalent?

  2005cited by this paper
• Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma

  2005cited by this paper
• Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer.

  2005cited by this paper
• Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.

  2005cited by this paper
• Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

  2005cited by this paper
• Contouring the Middle and Inner Ear on Radiotherapy Planning Scans

  2005cited by this paper
• Level II lymph nodes and radiation-induced xerostomia.

  2004cited by this paper
• Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.

  2004cited by this paper
• Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

  2004cited by this paper
• Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

  2004cited by this paper
• Mandibular osteoradionecrosis.

  2004cited by this paper
• Friendly Fire: Neurogenic Visual Loss From Radiation Therapy

  2004cited by this paper
• Lack of Radiation Optic Neuropathy in 72 Patients Treated for Pituitary Adenoma

  2004cited by this paper
• Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.

  2004cited by this paper
• Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.

  2004cited by this paper
• Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma.

  2004cited by this paper
• CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

  2003cited by this paper
• How should we measure and report radiotherapy-induced xerostomia?

  2003cited by this paper
• Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.

  2003cited by this paper
• Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.

  2002cited by this paper
• Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.

  2002cited by this paper
• Preservation of parotid function with uncomplicated conformal radiotherapy.

  2002cited by this paper
• Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.

  2002cited by this paper
• Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors.

  2002cited by this paper
• Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.

  2002cited by this paper
• Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.

  2002cited by this paper
• Late radiation effects on hearing, vestibular function, and taste in brain tumor patients.

  2002cited by this paper
• Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.

  2002cited by this paper
• Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature.

  2002cited by this paper
• Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients.

  2002cited by this paper
• Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

  2001cited by this paper

• Dosimetric assessment of deep learning based organ-at-risk segmentation: insights from the HaN-Seg challenge.

  2026cites this paper
• From Salivary Dysfunction to Prosthetic Challenges in Xerostomia and Denture Retention with Oral Gels

  2025cites this paper
• Isoliquiritigenin as a Neuronal Radiation Mitigant: Mitigating Radiation-Induced Anhedonia Tendency Targeting Grik3/Grm8/Grin3a via Integrated Proteomics and AI-Driven Discovery

  2025cites this paper
• Multimodal fusion model for prognostic prediction and radiotherapy response assessment in head and neck squamous cell carcinoma

  2025cites this paper
• Elucidating the complexity of radiation-induced brain injury: comprehensive assessment of hippocampal and cortical impacts

  2025cites this paper
• Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries

  2024cites this paper
• A radiotherapy community data‐driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracy

  2024influential citation
• High doses of radiation cause cochlear immunological stress and sensorineural hearing loss

  2024cites this paper
• Radiation therapy: An old dog learning new tricks.

  2023cites this paper
• Dose to Dysphagia–Aspiration-related Structures and Its Effect on Dysphagia in Patients of Carcinoma Oropharynx: Three-dimensional Conformal Radiotherapy versus Intensity-modulated Radiotherapy: A Prospective Study

  2023cites this paper
• Radiation therapy: An old dog learning new tricks.

  2023cites this paper
• Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma

  2023cites this paper
• A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury

  2023cites this paper
• Investigation of the Effect of Radiotherapy Dose on Chewing and Swallowing Structures in Head and Neck Cancer Patients Treated with Concomitant Chemoradiotherapy

  2022cites this paper
• Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints.

  2022cites this paper
• Radiation therapy: An old dog learning new tricks.

  2022cites this paper
• Cytofluorometric assessment of acute cell death responses driven by radiation therapy.

  2022cites this paper
• Diagnostic Challenges in Osteoradionecrosis of the Jaw

  2022cites this paper
• Tooth Extraction Within 2 Weeks Before Radiotherapy and Osteoradionecrosis: A Nationwide Cohort Study.

  2022cites this paper
• Risk Factors for Feeding Tube Dependency in Patients Undergoing Function Preservation Surgery for Advanced-Stage Laryngohypopharyngeal Cancer

  2022cites this paper
• Outcomes after definitive surgery for mandibular osteoradionecrosis

  2022cites this paper
• Presence and duration of feeding tube in a 5‐year cohort of patients with head and neck cancer treated with curative intensity‐modulated radiation therapy

  2021cites this paper
• Benefits of intraoral stents for sparing normal tissue in radiotherapy of nasopharyngeal carcinoma: a radiobiological model-based quantitative analysis

  2021cites this paper
• FOXC2/ADAM12‐dependent radiosensitivity of head and neck squamous cell carcinoma cells

  2021cites this paper
• Recent Advances in Functional Carbon Quantum Dots for Antitumour

  2021cites this paper
• Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients

  2020cites this paper
• Radiation therapy for parotid gland tumors: long term data from a large single Institution experience.

  2020cites this paper
• Oral pH value predicts the incidence of radiotherapy related caries in nasopharyngeal carcinoma patients

  2020cites this paper
• Utilising radiotherapy dose to guide 3D surgical reconstructions for mandibular osteoradionecrosis

  2020cites this paper
• Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma

  2020cites this paper
• Long-term maintenance of acinar cells in human submandibular glands after radiation therapy.

  2020cites this paper
• Radiotherapy in the management of glottic squamous cell carcinoma

  2020cites this paper
• Radiation Therapy and Mandibular Osteoradionecrosis: State of the Art

  2020cites this paper
• Upregulation of Circular RNA circATRNL1 to Sensitize Oral Squamous Cell Carcinoma to Irradiation

  2020cites this paper
• Automation and individualization of radiotherapy treatment planning in head and neck cancer patients

  2019influential citation
• Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?

  2019cites this paper
• Systematic review and meta‐analysis of the impact of dosimetry to dysphagia and aspiration related structures

  2019cites this paper
• Osteoradionecrosis and Antiresorptive Drug-Related Osteonecrosis of the Jaws

  2019cites this paper
• Optimization of time-dose fractionation radiotherapy scheme by simulated annealing with consideration of biological factor

  2018cites this paper
• Development of deep neural network for individualized hepatobiliary toxicity prediction after liver SBRT

  2018cites this paper
• The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review

  2018cites this paper
• Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma

  2018cites this paper
• Prediction of radiotherapy response with a 5‐microRNA signature‐based nomogram in head and neck squamous cell carcinoma

  2018influential citation
• Optimising volumetric arc radiotherapy for dental rehabilitation in oropharynx cancer - A retrospective dosimetry review and feasibility planning study.

  2018cites this paper
• Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.

  2018cites this paper
• [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].

  2017cites this paper
• Charged-particle therapy in cancer: clinical uses and future perspectives

  2017cites this paper
• Compliance, Pain Experience, and Outcomes from Dysphagia Exercises in Individuals with Oropharyngeal Cancer with Latent Dysphagia

  2017influential citation
• Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis.

  2017cites this paper
• Comprehensive Rehabilitation of Oral Cancer

  2017cites this paper
• Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy

  2017cites this paper
• Design and fabrication of a 3D–printed oral stent for head and neck radiotherapy from routine diagnostic imaging

  2017cites this paper
• The Effect of Head and Neck Radiotherapy on Blood Pressure and Orthostatic Hypotension in Patients With Head and Neck Tumors

  2016cites this paper
• A closer look at strategies for preserving salivary gland function after radiotherapy in the head and neck region.

  2016cites this paper
• Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.

  2016cites this paper
• Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.

  2016cites this paper
• Radiation dose to the tongue and velopharynx predicts acoustic-articulatory changes after chemo-IMRT treatment for advanced head and neck cancer

  2016cites this paper
• Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy

  2016cites this paper
• Treatment outcome of ion beam therapy in eight patients with head and neck cancers

  2016cites this paper
• Laryngeal cancer in Finland: A 5‐year follow‐up study of 366 patients

  2016cites this paper
• Overcoming radioresistance in head and neck squamous cell carcinoma.

  2016cites this paper
• Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.

  2016cites this paper
• Osteoradionecrosis and intensity modulated radiation therapy: An overview.

  2016cites this paper
• Sequelae of Therapy of Head and Neck Cancer: Their Prevention and Therapy

  2015cites this paper
• IGRT for IMRT

  2015cites this paper
• Optimising intratumoural treatment of head and neck squamous cell carcinoma mouse models with EBC-46

  2015cites this paper
• Effective Biomarkers and Radiation Treatment in Head and Neck Cancer.

  2015cites this paper
• Predicting Depression and Quality of Life among Long-term Head and Neck Cancer Survivors

  2015cites this paper
• Weekly kilovoltage cone-beam computed tomography for detection of dose discrepancies during (chemo)radiotherapy for head and neck cancer

  2015cites this paper
• Oral and oropharyngeal cancer.

  2014cites this paper
• Sparing functional anatomical structures during intensity-modulated radiotherapy: an old problem, a new solution.

  2014influential citation
• Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.

  2014cites this paper
• Effects of the dose-volume relationship on and risk factors for maxillary osteoradionecrosis after carbon ion radiotherapy

  2014cites this paper
• Differential Expression of Stress and Immune Response Pathway Transcripts and miRNAs in Normal Human Endothelial Cells Subjected to Fractionated or Single-Dose Radiation

  2014cites this paper
• BJRD14543 1..10

  2014cites this paper
• XRCC3 polymorphisms are associated with the risk of developing radiation-induced late xerostomia in nasopharyngeal carcinoma patients treated with intensity modulation radiated therapy.

  2014cites this paper
• Impact of HPV on Oropharyngeal Cancer Biology and Response to Therapy: Implications for Treatment

  2013cites this paper
• Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.

  2013cites this paper
• Late term tolerance in head neck cancer patients irradiated in the IMRT era

  2013cites this paper
• Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.

  2013cites this paper
• Nutritional Management for Head and Neck Cancer Patients

  2013cites this paper
• Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.

  2013cites this paper
• Radiation Survivors: Understanding and Exploiting the Phenotype following Fractionated Radiation Therapy

  2012cites this paper
• Ear-Related Issues in Patients with Nasopharyngeal Carcinoma

  2012cites this paper
• Biological mechanisms of normal tissue damage: importance for the design of NTCP models.

  2012cites this paper
• 9 Ear-Related Issues in Patients with Nasopharyngeal Carcinoma

  2012cites this paper